1,493 results on '"Beal, M. Flint"'
Search Results
2. Mitochondrial dysfunction and energy metabolism in amyotrophic lateral sclerosis
3. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
4. A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit
5. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
6. Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations
7. PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All
8. Inactivation of Drosophila DJ-1 Leads to Impairments of Oxidative Stress Response and Phosphatidylinositol 3-Kinase/Akt Signaling
9. Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease
10. Alzheimer's Brains Harbor Somatic mtDNA Control-Region Mutations That Suppress Mitochondrial Transcription and Replication
11. Common threads in neurodegenerative disorders of aging.
12. Coenzyme Q 10 Administration Increases Brain Mitochondrial Concentrations and Exerts Neuroprotective Effects
13. Mutations in Mitochondrial Cytochrome c Oxidase Genes Segregate with Late-Onset Alzheimer Disease
14. Introduction and Historical Notes : Excitotoxicity in Neurologic Diseases
15. Excitotoxicity in Huntington’s Disease
16. Potential Therapies for Mitochondrial Dysfunction
17. Parkinson's disease: a model dilemma
18. Metabolomics: A New Approach Towards Identifying Biomarkers and Therapeutic Targets in CNS Disorders
19. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis
20. Nitration of Hsp90 induces cell death
21. Systemic Administration of 3-Nitropropionic Acid : A New Model of Huntington’s Disease in Rat
22. Muscling In on PGC-1α for Improved Quality of Life in ALS
23. Mitochondrial Dysfunction and Neurodegenerative Diseases
24. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases
25. Therapeutic Strategies in Alzheimer’s Disease
26. The Role of Oxidative Processes and Metal Ions in Aging and Alzheimer’s Disease
27. Pink1 Regulates Mitochondrial Dynamics through Interaction with the Fission/Fusion Machinery
28. Bioenergetics in Oxidative Damage in Neurodegenerative Diseases
29. Inhibition of the Leucine-Rich Repeat Protein LINGO-1 Enhances Survival, Structure, and Function of Dopaminergic Neurons in Parkinson's Disease Models
30. Mitochondrial Pathology and Muscle and Dopaminergic Neuron Degeneration Caused by Inactivation of Drosophila Pink1 Is Rescued by Parkin
31. Mechanisms of Neuronal Degeneration in Huntington’s Disease
32. Mitochondrial Dysfunction, Aging, and Huntington’s Disease
33. Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo
34. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
35. Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease
36. Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
37. Patterns of Tyrosine and Tryptophan Metabolites in Controls and Various Degenerative Disorders
38. Generating and Controlling Multiparameter Data Bases for Biochemical Correlates of Disorders
39. Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics
40. Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model
41. Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition
42. Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
43. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease
44. Lenalidomide (Revlimid ®) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis
45. Chronic Mitochondrial Energy Impairment Produces Selective Striatal Degeneration and Abnormal Choreiform Movements in Primates
46. Implanted Fibroblasts Genetically Engineered to Produce Brain-Derived Neurotrophic Factor Prevent 1-Methyl-4-Phenylpyridinium Toxicity to Dopaminergic Neurons in the Rat
47. An in vivo Model for the Neurodegenerative Effects of β Amyloid and Protection by Substance P
48. Two Types of Somatostatin Receptors Differentiated by Cyclic Somatostatin Analogs
49. Neuroprotective effects of creatine
50. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.